Bayer Earnings Beat Forecasts on Strong Crop Science Performance
Bayer AG's earnings beat estimates fueled by crop science strength, signaling robust demand in the agricultural sector.
Bayer AG's earnings beat estimates fueled by crop science strength, signaling robust demand in the agricultural sector.
Bayer divests contraceptive division stake to Apollo in a €3 billion deal, boosting its balance sheet and refocusing its pharmaceutical strategy.
Bayer's Supreme Court Roundup win offers partial relief but leaves intact the bulk of cancer litigation risks, keeping pressure on the stock's…
Investors brace for Bayer court rulings after a $60 billion share price collapse.